Daxxify

Help achieve the look of your dreams.
Daxxify is the latest FDA-approved neurotoxin, offering longer-lasting results compared to traditional options. With effects that can last up to 6 months or more, Daxxify is perfect for those seeking a more durable solution to dynamic wrinkles.
Key Benefits of Daxxify
- Longer-lasting results, potentially up to 6 months or more
- Innovative peptide formulation
- May require fewer treatments per year
- Potentially more cost-effective in the long run due to less frequent treatments
Daxxify, approved by the FDA in 2022, represents the newest innovation in neurotoxin treatments. Its unique formulation includes a peptide exchange technology that allows it to bind more strongly to nerve endings, resulting in a longer duration of effect. Daxxify is currently FDA-approved for treating frown lines between the eyebrows (glabellar lines).
The treatment process for Daxxify is similar to that for other neurotoxins, taking about 10-15 minutes. Results begin to appear within a few days, with full effects visible after 7-14 days. The standout feature of Daxxify is its longevity—clinical studies have shown that results can last six months or even longer in some patients.
Daxxify is ideal for adults who want to reduce the appearance of frown lines and are looking for a longer-lasting solution. It's particularly well-suited for those who prefer less frequent treatments or have busy schedules that make regular appointments challenging.